|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Department of Medical and Surgical Sciences, University-Hospital of Padova, Via Giustiniani 2, 35128 Padova, Italy
2 Department of Laboratory Medicine, University-Hospital of Padova
3 Department of Pathology, University-Hospital of Padova
Correspondence to:
Dr M Plebani, Department of Laboratory Medicine, University-Hospital of Padova, Via Giustiniani 2, 35128 Padova, Italy;
pd08821{at}pd.nettuno.it
Aims: To determine any associations between the Helicobacter pylori genes babA2, oipA, cagA and the s and m alleles of vacA. In addition, to verify whether these genes work synergistically or independently in causing gastritis, peptic ulcer, and intestinal metaplasia.
Methods: One hundred and sixty seven H pylori positive patients were studied (52 antral gastritis, 41 diffuse gastritis, 41 peptic ulcer, and 33 duodenitis). Helicobacter pylori virulence genes were amplified by means of the polymerase chain reaction.
Results: Significant associations were found between babA2 and the other H pylori genes studied. When considered singly, all the genes were associated with disease diagnosis, inflammation, and intestinal metaplasia. Four H pylori groups were defined. Group A: cagA-, s2m2, babA2-; group B: cagA+, s1m1, babA2+; group C: cagA+, s1m2, babA2+; group D: cagA+, s1m2, babA2-. Group A infecting strains were associated with less severe endoscopic and inflammatory conditions, whereas group B strains were associated with the worst endoscopic and inflammatory findings. Intestinal metaplasia was a rare finding in group A infected patients (< 10%), whereas it was frequent in those infected with group B strains (48%).
Conclusions: The H pylori genes cagA, oipA "on", s1 and m1 vacA, and babA2 are associated with each other, possibly as a result of shared selective pressure. When coexpressed by the same H pylori strain, cagA, s1 and m1 vacA, and babA2 work synergistically in worsening inflammation. Infections caused by strains coexpressing cagA, s1m1 vacA, and babA2 are those at higher risk for intestinal metaplasia.
Keywords: babA2; intestinal metaplasia; cagA; vacA
Abbreviations: IL, interleukin; NS, not significant; PAI, pathogenicity island; PCR, polymerase chain reaction
This article has been cited by other articles:
![]() |
M. Douraghi, M. Mohammadi, A. Oghalaie, A. Abdirad, M. A. Mohagheghi, M. E. Hosseini, H. Zeraati, A. Ghasemi, M. Esmaieli, and N. Mohajerani dupA as a risk determinant in Helicobacter pylori infection J. Med. Microbiol., May 1, 2008; 57(5): 554 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Emilia, M. Luppi, P. Zucchini, M. Morselli, L. Potenza, F. Forghieri, F. Volzone, G. Jovic, G. Leonardi, A. Donelli, et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles Blood, December 1, 2007; 110(12): 3833 - 3841. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wen, D. Velin, C. P. Felley, L. Du, P. Michetti, and Q. Pan-Hammarstrom Expression of Helicobacter pylori Virulence Factors and Associated Expression Profiles of Inflammatory Genes in the Human Gastric Mucosa Infect. Immun., November 1, 2007; 75(11): 5118 - 5126. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Peleteiro, N. Lunet, C. Figueiredo, F. Carneiro, L. David, and H. Barros Smoking, Helicobacter pylori Virulence, and Type of Intestinal Metaplasia in Portuguese Males Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 322 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Navaglia, D Basso, C-F Zambon, E Ponzano, L Caenazzo, N Gallo, A Falda, C Belluco, P Fogar, E Greco, et al. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals J. Med. Genet., June 1, 2005; 42(6): 503 - 510. [Full Text] [PDF] |
||||
![]() |
F. Kauser, M. A. Hussain, I. Ahmed, N. Ahmad, A. Habeeb, A. A. Khan, and N. Ahmed Comparing Genomes of Helicobacter pylori Strains from the High-Altitude Desert of Ladakh, India J. Clin. Microbiol., April 1, 2005; 43(4): 1538 - 1545. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |